Lymphogranuloma venereum: Difference between revisions
No edit summary |
m (Changes made per Mahshid's request) |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 5: | Line 5: | ||
{{CMG}} | {{CMG}} | ||
{{SK}} Durand-Nicolas-Favre disease; LGV; lymphogranuloma inguinale; lymphopathia venereum; | {{SK}} Durand-Nicolas-Favre disease; Nicolas-Favre disease; LGV; lymphogranuloma inguinale; lymphopathia venereum; lymphopathia venerea; poradenitis inguinale; poradentitis; tropical bubo; climatic bubo; strumous bubo; sixth venereal disease | ||
==[[Lymphogranuloma venereum overview|Overview]]== | ==[[Lymphogranuloma venereum overview|Overview]]== | ||
==[[Lymphogranuloma venereum historical perspective|Historical Perspective]]== | ==[[Lymphogranuloma venereum historical perspective|Historical Perspective]]== | ||
==[[Lymphogranuloma venereum pathophysiology|Pathophysiology]]== | ==[[Lymphogranuloma venereum pathophysiology|Pathophysiology]]== | ||
==[[Chlamydia trachomatis|Causes]]== | |||
==[[Lymphogranuloma venereum classification|Classification]]== | |||
==[[Lymphogranuloma venereum differential diagnosis|Differentiating Lymphogranuloma venereum from other Diseases]]== | ==[[Lymphogranuloma venereum differential diagnosis|Differentiating Lymphogranuloma venereum from other Diseases]]== | ||
==[[Lymphogranuloma venereum epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Lymphogranuloma venereum epidemiology and demographics|Epidemiology and Demographics]]== | ||
| Line 19: | Line 21: | ||
==Treatment== | ==Treatment== | ||
[[Lymphogranuloma venereum medical therapy|Medical Therapy]] | [[Lymphogranuloma venereum surgery|Surgery]] | [[Lymphogranuloma venereum | [[Lymphogranuloma venereum medical therapy|Medical Therapy]] | [[Lymphogranuloma venereum surgery|Surgery]] | [[Lymphogranuloma venereum prevention|Prevention]] | [[Lymphogranuloma venereum cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Lymphogranuloma venereum future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Lymphogranuloma venereum case study one|Case #1]] | [[Lymphogranuloma venereum case study one|Case #1]] | ||
{{STD/STI}} | {{STD/STI}} | ||
| Line 38: | Line 37: | ||
[[fi:Neekerisankkeri]] | [[fi:Neekerisankkeri]] | ||
[[sv:Lymphogranuloma venereum]] | [[sv:Lymphogranuloma venereum]] | ||
[[Category:Bacterial diseases]] | |||
[[Category:Sexually transmitted diseases]] | [[Category:Sexually transmitted diseases]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 17:59, 18 September 2017
For patient information, click here
|
Lymphogranuloma venereum Microchapters |
|
Differentiating Lymphogranuloma venereum from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Lymphogranuloma venereum On the Web |
|
American Roentgen Ray Society Images of Lymphogranuloma venereum |
|
Risk calculators and risk factors for Lymphogranuloma venereum |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Durand-Nicolas-Favre disease; Nicolas-Favre disease; LGV; lymphogranuloma inguinale; lymphopathia venereum; lymphopathia venerea; poradenitis inguinale; poradentitis; tropical bubo; climatic bubo; strumous bubo; sixth venereal disease
Overview
Historical Perspective
Pathophysiology
Causes
Classification
Differentiating Lymphogranuloma venereum from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Template:STD/STI Template:Bacterial diseases
de:Lymphogranuloma venereum
nl:Lymfogranuloma venereum
fi:Neekerisankkeri
sv:Lymphogranuloma venereum